Multicentre comparison of a diagnostic assay: Aquaporin-4 antibodies in neuromyelitis optica

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 9, 2016, Pages 1005-1015

  Waters, Patrick ^a   Reindl, Markus ^b   Saiz, Albert ^c   Schanda, Kathrin ^b   Tuller, Friederike ^b   Kral, Vlastimil ^d   Nytrova, Petra ^e   Sobek, Ondrej ^f   Nielsen, Helle Hvilsted ^g   Barington, Torben ^g   Lillevang, Søren T ^g   Illes, Zsolt ^h,i   Rentzsch, Kristin ^j   Berthele, Achim ^k   Berki, Tímea ⁱ   Granieri, Letizia ^l   Bertolotto, Antonio ^l   Giometto, Bruno ^m   Zuliani, Luigi ^m   Hamann, Dörte ⁿ   Van Pelt, E Daniëlle ^o   Hintzen, Rogier ^o   Höftberger, Romana ^c,p   Costa, Carme ^q   Comabella, Manuel ^q   Montalban, Xavier ^q   Tintoré, Mar ^q   Siva, Aksel ^r   Altintas, Ayse ^r   Deniz, Günnur ^s   Woodhall, Mark ^a   Palace, Jacqueline ^a   Paul, Friedemann ^t   Hartung, Hans Peter ^u   Aktas, Orhan ^u   Jarius, Sven ^v   Wildemann, Brigitte ^v   Vedeler, Christian ^w,x   Ruiz, Anne ^y   Leite, M Isabel ^a   Trillenberg, Peter ^z   Probst, Monika ^aa   Saschenbrecker, Sandra ^j   Vincent, Angela ^a   Marignier, Romain ^y   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Centrum Imunologie A Mikrobiologie Zdravotního Ústavu Se Sídlem v Ústí Nad Labem   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Topelex Ltd   (Czech Republic)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

^h UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

ⁱ UNIVERSITY OF PÉCS   (Hungary)

^j Institute of Experimental Immunology   (Germany)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^m Azienda ULSS 9   (Italy)

ⁿ Sanquin Diagnostiek   (Netherlands)

^o ERASMUS MEDICAL CENTER   (Netherlands)

^p MEDICAL UNIVERSITY OF VIENNA   (Austria)

^q UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^r ISTANBUL UNIVERSITY   (Turkey)

^s ISTANBUL UNIVERSITY   (Turkey)

^t CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^u HEINRICH HEINE UNIVERSITY   (Germany)

^v UNIVERSITY OF HEIDELBERG   (Germany)

^w UNIVERSITY OF BERGEN   (Norway)

^x HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^y LYON NEUROSCIENCE RESEARCH CENTER   (France)

^z UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^aa Institute for Quality Assurance   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AQUAPORIN 4; AUTOANTIBODY;

ARTICLE; CELL BASED ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AQUAPORIN 4; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROMYELITIS OPTICA; SENSITIVITY AND SPECIFICITY;

EID: 84965014247     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2015-312601     Document Type: Article

References (30)

1. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-7.
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
3. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36.
4. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66: 11-18.
5. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008; 71: 1291-2.
6. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65: 424-34.
7. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010; 9: 67-76.
8. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9: 776-85.
9. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-48.
10. Lancaster E, Huijbers MGM, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011; 69: 303-11.
11. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to GABAA receptor: a case series, characterisation of the antigen and analysis of the effects of antibodies. Lancet Neurol 2014; 13: 276-86.
12. Pettingill P, Kramer HB, Coebergh JA, et al. Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization. Neurology 2015; 84: 1233-41.
13. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010; 257: 509-17.
14. Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011; 10: 759-72.
15. Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro Oncol 2014; 16: 771-8.
16. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.
17. Waters PJ, Pittock SJ, Bennett JL, et al. Evaluation of aquaporin-4 antibody assays. Clin Exp Neuroimunol 2014; 5: 290-303.
18. Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 2013; 23: 661-83.
19. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-6.
20. Morris KA, Waters P, Woodhall MR, et al. A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies. Neurol Neuroimmunol Neuroinflamm 2015; 2: e88.
21. Leite MI, Coutinho E, Lana-Peixoto M, et al. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicentre study of 16 patients. Neurology 2012; 78: 1601-7.
22. Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008; 70: 2197-200.
23. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006; 59: 566-9.
24. Waters P, Woodhall M, O'Connor KC, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2015; 2: e89.
25. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007; 130: 1235-43.
26. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012; 78: 665-71; discussion 669.
27. Höftberger R, Sabater L, Marignier R, et al. An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assay. PLoS ONE 2013; 8: e79083.
28. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 1-13.
29. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474-81.
30. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-65.